Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status

NCT01629940 is registered in ClinicalTrials.gov with Edimer Pharmaceuticals as lead sponsor.

NCT NCT01629940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01629940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenotypic and Genetic Properties in Males at Risk for X-linked Hypohidrotic Ectodermal Dysplasia: Evaluation of an Early Diagnosis Technology and Tests to Assess Nutritional Status
Lead sponsor
Edimer Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
October 31, 2012
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypohidrotic ectodermal dysplasia, x-linked hypohidrotic ectodermal dysplasia